The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1.
本发明涉及11-β羟基类
固醇脱氢酶1型的
抑制剂及其制药组合物。本发明的化合物可用于治疗与11-β羟基类
固醇脱氢酶1型的表达或活性相关的各种疾病。